Effects of hypochlorous acid mouthwash on salivary bacteria including Staphylococcus aureus in patients with periodontal disease: a randomized controlled trial.


Journal

BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684

Informations de publication

Date de publication:
28 09 2023
Historique:
received: 26 04 2023
accepted: 26 08 2023
medline: 2 10 2023
pubmed: 29 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

The effects of a low concentration of hypochlorous acid (HOCl) mouthwash on salivary bacteria remained unclear. We aimed to evaluate the antibacterial effects of 100 ppm HOCl mouthwash on salivary bacteria, including Staphylococcus aureus (S. aureus), in patients with periodontal disease (PD). Patients with PD were randomized into mouthwash-only (MW, n = 26) and mouthwash with periodontal flosser (MWPF, n = 27) groups. Patients without PD were selected for the control group (n = 30). S. aureus culture and saliva samples (before and after the intervention) were collected for bacterial DNA extraction. A real-time polymerase chain reaction assay and serial dilutions of S. aureus culture and saliva samples were used to measure the salivary bacteria total count (SBTC) and confirm the antibacterial effects of the mouthwash using S. aureus. No significant difference in demographic data was observed among the three groups. Before the intervention, the baseline SBTC of the MW and MWPF groups was significantly higher than that of the control group. After the mouthwash rinses, the SBTC data significantly changed in the MW and MWPF groups only (by 62.4% and 77.4%, respectively). After the base-2 log-transformation of the SBTC data, a similar trend was observed. Linear regression revealed that baseline SBTC and the MWPF intervention significantly affected SBTC reduction percentage by volume. After incubation with 10% (v/v) of mouthwash, the survival rates of 10 These study results indicated that 100 ppm HOCl mouthwash treatment could effectively reduce SBTC in patients with PD and the abundance of S. aureus. It provides that the HOCl mouthwash can be an option for individuals to help control SBTC, especially in patients with PD. The study protocol was approved by the Institutional Review Board of Kaohsiung Medical University Hospital (KMUHIRB-F(I)-20200042) on 20/03/2020 and retrospectively registered at ClinicalTrial.gov (NCT05372835) on 13/05/2022.

Sections du résumé

BACKGROUND
The effects of a low concentration of hypochlorous acid (HOCl) mouthwash on salivary bacteria remained unclear. We aimed to evaluate the antibacterial effects of 100 ppm HOCl mouthwash on salivary bacteria, including Staphylococcus aureus (S. aureus), in patients with periodontal disease (PD).
METHODS
Patients with PD were randomized into mouthwash-only (MW, n = 26) and mouthwash with periodontal flosser (MWPF, n = 27) groups. Patients without PD were selected for the control group (n = 30). S. aureus culture and saliva samples (before and after the intervention) were collected for bacterial DNA extraction. A real-time polymerase chain reaction assay and serial dilutions of S. aureus culture and saliva samples were used to measure the salivary bacteria total count (SBTC) and confirm the antibacterial effects of the mouthwash using S. aureus.
RESULTS
No significant difference in demographic data was observed among the three groups. Before the intervention, the baseline SBTC of the MW and MWPF groups was significantly higher than that of the control group. After the mouthwash rinses, the SBTC data significantly changed in the MW and MWPF groups only (by 62.4% and 77.4%, respectively). After the base-2 log-transformation of the SBTC data, a similar trend was observed. Linear regression revealed that baseline SBTC and the MWPF intervention significantly affected SBTC reduction percentage by volume. After incubation with 10% (v/v) of mouthwash, the survival rates of 10
CONCLUSIONS
These study results indicated that 100 ppm HOCl mouthwash treatment could effectively reduce SBTC in patients with PD and the abundance of S. aureus. It provides that the HOCl mouthwash can be an option for individuals to help control SBTC, especially in patients with PD.
TRIAL REGISTRATION
The study protocol was approved by the Institutional Review Board of Kaohsiung Medical University Hospital (KMUHIRB-F(I)-20200042) on 20/03/2020 and retrospectively registered at ClinicalTrial.gov (NCT05372835) on 13/05/2022.

Identifiants

pubmed: 37770865
doi: 10.1186/s12903-023-03358-4
pii: 10.1186/s12903-023-03358-4
pmc: PMC10540437
doi:

Substances chimiques

Mouthwashes 0
Hypochlorous Acid 712K4CDC10
Anti-Bacterial Agents 0

Banques de données

ClinicalTrials.gov
['NCT05372835']

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

698

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Rajendiran M, Trivedi HM, Chen D, Gajendrareddy P, Chen L. Recent Development of Active Ingredients in Mouthwashes and Toothpastes for Periodontal Diseases. Molecules. 2021;26:2001.
doi: 10.3390/molecules26072001 pubmed: 33916013 pmcid: 8037529
Lertpimonchai A, Rattanasiri S, Arj-Ong Vallibhakara S, Attia J, Thakkinstian A. The association between oral hygiene and periodontitis: a systematic review and meta-analysis. Int Dent J. 2017;67:332–43.
doi: 10.1111/idj.12317 pubmed: 28646499
Lang NP, Schatzle MA, Loe H. Gingivitis as a risk factor in periodontal disease. J Clin Periodontol. 2009;36(Suppl 10):3–8.
doi: 10.1111/j.1600-051X.2009.01415.x pubmed: 19432625
Palmer RJ. Oral bacterial biofilms–history in progress. Microbiology. 2009;155:2113–4.
doi: 10.1099/mic.0.030809-0 pubmed: 19460821 pmcid: 2888113
Bowen WH, Burne RA, Wu H, Koo H. Oral Biofilms: Pathogens, Matrix, and Polymicrobial Interactions in Microenvironments. Trends Microbiol. 2018;26:229–42.
doi: 10.1016/j.tim.2017.09.008 pubmed: 29097091
Takenaka S, Ohsumi T, Noiri Y. Evidence-based strategy for dental biofilms: Current evidence of mouthwashes on dental biofilm and gingivitis. Jpn Dent Sci Rev. 2019;55:33–40.
doi: 10.1016/j.jdsr.2018.07.001 pubmed: 30733843
Lee PP, Mak WY, Newsome P. The aetiology and treatment of oral halitosis: an update. Hong Kong Med J. 2004;10:414–8.
pubmed: 15591601
Furquim Dos Santos Cardoso V, Amaral Roppa RH, Antunes C, Silva Moraes AN, Santi L, Konrath EL. Efficacy of medicinal plant extracts as dental and periodontal antibiofilm agents: A systematic review of randomized clinical trials. J Ethnopharmacol. 2021;281:114541.
doi: 10.1016/j.jep.2021.114541 pubmed: 34416298
Grover V, Mahendra J, Gopalakrishnan D, Jain A. Effect of octenidine mouthwash on plaque, gingivitis, and oral microbial growth: A systematic review. Clin Exp Dent Res. 2021;7:450–64.
doi: 10.1002/cre2.386 pubmed: 34227746 pmcid: 8404485
Van der Weijden FA, Van der Sluijs E, Ciancio SG, Slot DE. Can Chemical Mouthwash Agents Achieve Plaque/Gingivitis Control? Dent Clin North Am. 2015;59:799–829.
doi: 10.1016/j.cden.2015.06.002 pubmed: 26427569
Castillo DM, Castillo Y, Delgadillo NA, Neuta Y, Jola J, Calderon JL, et al. Viability and Effects on Bacterial Proteins by Oral Rinses with Hypochlorous Acid as Active Ingredient. Braz Dent J. 2015;26:519–24.
doi: 10.1590/0103-6440201300388 pubmed: 26647939
Levine JM. Dakin’s solution: past, present, and future. Adv Skin Wound Care. 2013;26:410–4.
doi: 10.1097/01.ASW.0000432051.59348.cd pubmed: 23958873
Sakarya S, Gunay N, Karakulak M, Ozturk B, Ertugrul B. Hypochlorous Acid: an ideal wound care agent with powerful microbicidal, antibiofilm, and wound healing potency. Wounds. 2014;26:342–50.
pubmed: 25785777
Totoraitis K, Cohen JL, Friedman A. Topical Approaches to Improve Surgical Outcomes and Wound Healing: A Review of Efficacy and Safety. J Drugs Dermatol. 2017;16:209–12.
pubmed: 28301615
Kim C, Cha YN. Taurine chloramine produced from taurine under inflammation provides anti-inflammatory and cytoprotective effects. Amino Acids. 2014;46:89–100.
doi: 10.1007/s00726-013-1545-6 pubmed: 23933994
Green JN, Kettle AJ, Winterbourn CC. Protein chlorination in neutrophil phagosomes and correlation with bacterial killing. Free Radic Biol Med. 2014;77:49–56.
doi: 10.1016/j.freeradbiomed.2014.08.013 pubmed: 25236747
Van der Velden U, Van Winkelhoff AJ, Abbas F, De Graaff J. The habitat of periodontopathic micro-organisms. J Clin Periodontol. 1986;13:243–8.
doi: 10.1111/j.1600-051X.1986.tb01467.x pubmed: 3457811
Tazawa K, Jadhav R, Azuma MM, Fenno JC, McDonald NJ, Sasaki H. Hypochlorous acid inactivates oral pathogens and a SARS-CoV-2-surrogate. BMC Oral Health. 2023;23:111.
doi: 10.1186/s12903-023-02820-7 pubmed: 36803460 pmcid: 9938691
Koluman A, Aktas A, Adiloglu S. Antimicrobial activities of Ankaferd BloodStopper, hypochlorous acid, and chlorhexidine against specific organisms. Turk J Med Sci. 2022;52:276–8.
pubmed: 34688239
Hsieh YL, Yao JC, Hsieh SC, Teng NC, Chu YT, Yu WX, et al. The In Vivo Toxicity and Antimicrobial Properties for Electrolyzed Oxidizing (EO) Water-Based Mouthwashes. Materials (Basel). 2020;13:4299.
doi: 10.3390/ma13194299 pubmed: 32993124
da Silva-Boghossian CM, do Souto RM, Luiz RR, Colombo AP. Association of red complex, A. actinomycetemcomitans and non-oral bacteria with periodontal diseases. Arch Oral Biol. 2011;56:899–906.
doi: 10.1016/j.archoralbio.2011.02.009 pubmed: 21397893
Lourenco TGB, de Oliveira AM, Tsute Chen G, Colombo APV. Oral-gut bacterial profiles discriminate between periodontal health and diseases. J Periodontal Res. 2022;57:1227–37.
doi: 10.1111/jre.13059 pubmed: 36261869
Chiang TC, Huang MS, Lu PL, Huang ST, Lin YC. The effect of oral care intervention on pneumonia hospitalization, Staphylococcus aureus distribution, and salivary bacterial concentration in Taiwan nursing home residents: a pilot study. BMC Infect Dis. 2020;20:374.
doi: 10.1186/s12879-020-05061-z pubmed: 32460697 pmcid: 7251833
Fritschi BZ, Albert-Kiszely A, Persson GR. Staphylococcus aureus and other bacteria in untreated periodontitis. J Dent Res. 2008;87:589–93.
doi: 10.1177/154405910808700605 pubmed: 18502971
Al-Ouqaili MTS, Al-Kubaisy SHM, Al-Ani NFI. Biofilm antimicrobial susceptibility pattern for selected antimicrobial agents against planktonic and sessile cells of clinical isolates of staphylococci using MICs, BICs and MBECs. Asian J Pharmaceutics. 2018;12(4):S1375-83.
Marsh P, Martin M. Oral Microbiology 4th ed Butterworth-Heinemann. Oxford, United Kingdom: Lincare House, Jordan Hill; 1999.
Darout IA. Oral bacterial interactions in periodontal health and disease. J Dent Oral Hyg. 2014;6:7.
Uzel NG, Teles FR, Teles RP, Song XQ, Torresyap G, Socransky SS, et al. Microbial shifts during dental biofilm re-development in the absence of oral hygiene in periodontal health and disease. J Clin Periodontol. 2011;38:612–20.
doi: 10.1111/j.1600-051X.2011.01730.x pubmed: 21488936 pmcid: 3177321
Lafaurie GI, Zaror C, Diaz-Baez D, Castillo DM, De Avila J, Trujillo TG, et al. Evaluation of substantivity of hypochlorous acid as an antiplaque agent: A randomized controlled trial. Int J Dent Hyg. 2018;16:527–34.
doi: 10.1111/idh.12342 pubmed: 29608039
Ezzati K, Laakso EL, Salari A, Hasannejad A, Fekrazad R, Aris A. The Beneficial Effects of High-Intensity Laser Therapy and Co-Interventions on Musculoskeletal Pain Management: A Systematic Review. J Lasers Med Sci. 2020;11:81–90.
doi: 10.15171/jlms.2020.14 pubmed: 32099632 pmcid: 7008744
Goyal CR, Qaqish JG, Schuller R, Lyle DM. Evaluation of the Addition of a Water Flosser to Manual Brushing on Gingival Health. J Clin Dent. 2018;29:81–6.
pubmed: 30942963
Page RC. Gingivitis. J Clin Periodontol. 1986;13:345–59.
doi: 10.1111/j.1600-051X.1986.tb01471.x pubmed: 3522644
Isola G, Santonocito S, Distefano A, Polizzi A, Vaccaro M, Raciti G, et al. Impact of periodontitis on gingival crevicular fluid miRNAs profiles associated with cardiovascular disease risk. J Periodontal Res. 2023;58:165–74.
doi: 10.1111/jre.13078 pubmed: 36482859
Van Strydonck DA, Slot DE, Van der Velden U, Van der Weijden F. Effect of a chlorhexidine mouthrinse on plaque, gingival inflammation and staining in gingivitis patients: a systematic review. J Clin Periodontol. 2012;39:1042–55.
doi: 10.1111/j.1600-051X.2012.01883.x pubmed: 22957711
Block MS, Rowan BG. Hypochlorous Acid: A Review. J Oral Maxillofac Surg. 2020;78:1461–6.
doi: 10.1016/j.joms.2020.06.029 pubmed: 32653307 pmcid: 7315945

Auteurs

Ying-Chu Lin (YC)

School of Dentistry, College of Dental Medicine, Kaohsiung Medical University, No.100, Shih-Chuan 1st Road, Kaohsiung, 80708, Taiwan.

Cheng-Feng Tsai (CF)

School of Dentistry, College of Dental Medicine, Kaohsiung Medical University, No.100, Shih-Chuan 1st Road, Kaohsiung, 80708, Taiwan. jf3339891@yahoo.com.tw.
Wenhsin Dental Clinic, 1F, No. 182, Zhongzheng 2nd Rd., Xinxing Dist, Kaohsiung, Taiwan. jf3339891@yahoo.com.tw.

Hsiao-Ling Huang (HL)

Department of Oral Hygiene, College of Dental Medicine, Kaohsiung Medical University, No.100, Shih-Chuan 1st Road, Kaohsiung, 80708, Taiwan. hhuang@kmu.edu.tw.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH